OpenAlex
PricingAboutJobs
Log inGet started
Author

D. Li

Institution: Henan Provincial People's Hospital
Observed institutions: Henan Provincial People's Hospital, Zhengzhou People's Hospital
OpenAlex ID: A5021667734
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial
2025 · H-C. Sun, J. Fan, et al. · Annals of Oncology · 9
92P Safety of liver resection following atezolizumab plus bevacizumab treatment in hepatocellular carcinoma (HCC) patients with macrovascular invasion: A pre-specified analysis of the TALENTop study
2022 · H. Sun, F. Shen, et al. · Annals of Oncology · 5
PDF
Works count: 2
Citation count: 15
H-index: 2
I10-index: 1
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms